Knight Therapeutics Inc
F:04K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Knight Therapeutics Inc
F:04K
|
CA |
|
N
|
NH Special Purpose Acquisition 26 Co
KOSDAQ:439410
|
KR |
|
G
|
Garuda Metalindo Tbk PT
IDX:BOLT
|
ID |
|
D
|
Dongwon Development Co Ltd
KOSDAQ:013120
|
KR |
|
C
|
Cityland Development Corp
XPHS:CDC
|
PH |
|
D
|
Donnelley Financial Solutions Inc
F:1DN
|
US |
|
B
|
Bpost SA
F:13B
|
BE |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
SWB:UK2
|
CN |
|
Wawel SA
F:0K6
|
PL |
|
R
|
RFTech Co Ltd
KOSDAQ:061040
|
KR |
|
Big River Industries Ltd
F:BQ3
|
AU |
|
E
|
Edil San Felice SpA Societa Benefit
MIL:ESF
|
IT |
|
S
|
Sonic Automotive Inc
F:SA8A
|
US |
|
Stanmore Resources Ltd
F:S0D
|
AU |
|
Oracle Power PLC
LSE:ORCP
|
UK |
|
Q
|
Quantum eMotion Corp
AMEX:QNC
|
CA |
|
A
|
Amoeba SA
F:A1H
|
FR |
|
Novorossiyskiy Kombinat Khleboproduktov PAO
MOEX:NKHP
|
RU |
|
D
|
Defiance Silver Corp
F:D4E
|
CA |
|
A
|
Amines and Plasticizers Ltd
NSE:AMNPLST
|
IN |
|
A
|
Avertronics Inc
TPEX:3597
|
TW |
|
Catapult Sports Ltd
ASX:CAT
|
AU |
Bankruptcy Probability
Knight Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Knight Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
K
|
Knight Therapeutics Inc
TSX:GUD
|
1.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Knight Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Knight Therapeutics Inc has total debt of 14.6m CAD. This includes both short-term (0 CAD) and long-term (14.6m CAD) debt.
You can find a full breakdown on its Balance Sheet.